Fiche société
W.L.Gore & Associates
Traitements, essais et publications liés.
Traitements4programmes
Essais1liés
Publications3liées
SourceDBlocale
Traitements
4| Molécule | Indication / population | Phase | Objectif | Pays | Résultat |
|---|---|---|---|---|---|
| Actual device PFO closureMulti-center, prospective, randomized, placebo- and sham-controlled study to evaluate the GORE® CARDIOFORM Septal Occluder for migraine headache relief | Migraine | Non applicable | À vérifier | United States | À vérifier |
| Sham device PFO closureMulti-center, prospective, randomized, placebo- and sham-controlled study to evaluate the GORE® CARDIOFORM Septal Occluder for migraine headache relief | Migraine | Non applicable | À vérifier | United States | À vérifier |
| Thienopyridine (clopidogrel or prasugrel)Multi-center, prospective, randomized, placebo- and sham-controlled study to evaluate the GORE® CARDIOFORM Septal Occluder for migraine headache relief | Migraine | Non applicable | À vérifier | United States | À vérifier |
| Actual device PFO closureMulti-center, prospective, randomized, placebo- and sham-controlled study to evaluate the GORE® CARDIOFORM Septal Occluder for migraine headache relief | Migraine | Non applicable | À vérifier | United States | À vérifier |
Essais cliniques
1| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Actual device PFO closure | Migraine | Non applicable | NCT04100135 | RELIEF — GORE® CARDIOFORM Septal Occluder Migraine Clinical Study | TERMINATED |
Publications
3| Molécule | Indication / population | Titre | Journal | Date |
|---|---|---|---|---|
| Sham device PFO closure | Feasibility and safety of cryoballoon ablation for atrial fibrillation and closing patent foramen ovale without implantation: A pilot study. | Heart rhythm | ||
| Thienopyridine (clopidogrel or prasugrel) | Different duration of dual antiplatelet therapy after endovascular treatment for unruptured intracranial aneurysms. | Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia | ||
| Thienopyridine (clopidogrel or prasugrel) | Impact of dual antiplatelet therapy duration after percutaneous coronary intervention on outcomes in acute coronary syndrome patients with and without chronic kidney disease: a nationwide cohort study. | Renal failure |